{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:36:41Z","timestamp":1774492601652,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.7759\/cureus.47056","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T11:08:11Z","timestamp":1697368091000},"source":"Crossref","is-referenced-by-count":4,"title":["COVID-19 Vaccination and Its Relation to New-Onset Diabetes: A Narrative\u00a0Review"],"prefix":"10.7759","author":[{"given":"Deepa Rashmi","family":"Sivaprakasam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison Obinna","family":"Ohiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad S","family":"Asif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Shahabul","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Khubaib Gul","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Asad","family":"Nabeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rai Muhammad","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu F","year":"2020","unstructured":"Wu F, Zhao S, Yu B, et al.. A new coronavirus associated with human respiratory disease in China. Nature. 2020, 579:265-9. 10.1038\/s41586-020-2008-3","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112752","article-title":"COVID-19 diagnosis\u2014a review of current methods","volume":"172","author":"Y\u00fcce M","year":"2021","unstructured":"Y\u00fcce M, Filiztekin E, \u00d6zkaya KG. COVID-19 diagnosis\u2014a review of current methods. Biosens Bioelectron. 2021, 172:112752. 10.1016\/j.bios.2020.112752","journal-title":"Biosens Bioelectron"},{"key":"ref3","unstructured":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. (2020). Accessed. March 11, 2020: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang JK","year":"2006","unstructured":"Yang JK, Feng Y, Yuan MY, et al.. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006, 23:623-8. 10.1111\/j.1464-5491.2006.01861.x","journal-title":"Diabet Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang JK","year":"2010","unstructured":"Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010, 47:193-9. 10.1007\/s00592-009-0109-4","journal-title":"Acta Diabetol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","volume":"162","author":"Pal R","year":"2020","unstructured":"Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract. 2020, 162:108132. 10.1016\/j.diabres.2020.108132","journal-title":"Diabetes Res Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arteri.2020.10.001","article-title":"COVID-19 and diabetes: a bidirectional relationship","volume":"33","author":"Lima-Mart\u00ednez MM","year":"2021","unstructured":"Lima-Mart\u00ednez MM, Carrera Boada C, Madera-Silva MD, Mar\u00edn W, Contreras M. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2021, 33:151-7. 10.1016\/j.arteri.2020.10.001","journal-title":"Clin Investig Arterioscler"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.780663","article-title":"Diabetes and COVID-19; a bidirectional Interplay","volume":"13","author":"Kazakou P","year":"2022","unstructured":"Kazakou P, Lambadiari V, Ikonomidis I, et al.. Diabetes and COVID-19; a bidirectional Interplay. Front Endocrinol (Lausanne). 2022, 13:780663. 10.3389\/fendo.2022.780663","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.04.049","article-title":"COVID-19 and diabetes mellitus: an unholy interaction of two pandemics","volume":"14","author":"Pal R","year":"2020","unstructured":"Pal R, Bhadada SK. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr. 2020, 14:513-7. 10.1016\/j.dsx.2020.04.049","journal-title":"Diabetes Metab Syndr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2021.04.004","article-title":"Insulin resistance in COVID-19 and diabetes","volume":"15","author":"Govender N","year":"2021","unstructured":"Govender N, Khaliq OP, Moodley J, Naicker T. Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes. 2021, 15:629-34. 10.1016\/j.pcd.2021.04.004","journal-title":"Prim Care Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti K","year":"2021","unstructured":"Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021, 44:2645-55. 10.2337\/dc21-1318","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108382","article-title":"Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19","volume":"167","author":"Singh AK","year":"2020","unstructured":"Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020, 167:108382. 10.1016\/j.diabres.2020.108382","journal-title":"Diabetes Res Clin Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30895","article-title":"Diabetic ketoacidosis and COVID-19: a retrospective observational study","volume":"14","author":"Nagdev G","year":"2022","unstructured":"Nagdev G, Chavan G, Gadkari C, Sahu G. Diabetic ketoacidosis and COVID-19: a retrospective observational study. Cureus. 2022, 14:e30895. 10.7759\/cureus.30895","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576818","article-title":"Impact of diabetes in patients diagnosed with COVID-19","volume":"11","author":"Abu-Farha M","year":"2020","unstructured":"Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of diabetes in patients diagnosed with COVID-19. Front Immunol. 2020, 11:576818. 10.3389\/fimmu.2020.576818","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00244.2021","article-title":"Diabetic ketoacidosis and COVID-19: what have we learned so far?","volume":"322","author":"de S\u00e1-Ferreira CO","year":"2022","unstructured":"de S\u00e1-Ferreira CO, da Costa CH, Guimar\u00e3es JC, et al.. Diabetic ketoacidosis and COVID-19: what have we learned so far?. Am J Physiol Endocrinol Metab. 2022, 322:E44-53. 10.1152\/ajpendo.00244.2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110205","article-title":"Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: a systematic review, meta-analysis, and meta-regression","volume":"195","author":"Permana H","year":"2023","unstructured":"Permana H, Audi Yanto T, Ivan Hariyanto T. Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: a systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract. 2023, 195:110205. 10.1016\/j.diabres.2022.110205","journal-title":"Diabetes Res Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1878-9566","article-title":"Diabetes and COVID-19: short-and long-term consequences","volume":"54","author":"Steenblock C","year":"2022","unstructured":"Steenblock C, Hassanein M, Khan EG, et al.. Diabetes and COVID-19: short-and long-term consequences. Horm Metab Res. 2022, 54:503-9. 10.1055\/a-1878-9566","journal-title":"Horm Metab Res"},{"key":"ref18","unstructured":"DRAFT landscape of COVID-19 candidate vaccines - 10 December 2020. (2020). Accessed. October 12, 2023: https:\/\/www.who.int\/docs\/default-source\/a-future-for-children\/novel-coronavirus_landscape_covid-19.pdf."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab013","article-title":"Development of COVID-19 vaccines utilizing gene therapy technology","volume":"33","author":"Nakagami H","year":"2021","unstructured":"Nakagami H. Development of COVID-19 vaccines utilizing gene therapy technology. Int Immunol. 2021, 33:521-7. 10.1093\/intimm\/dxab013","journal-title":"Int Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23937","article-title":"Analysis of COVID-19 vaccines: types, thoughts, and application","volume":"35","author":"Han X","year":"2021","unstructured":"Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: types, thoughts, and application. J Clin Lab Anal. 2021, 35:e23937. 10.1002\/jcla.23937","journal-title":"J Clin Lab Anal"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202203_28248","article-title":"Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"26","author":"Huang YZ","year":"2022","unstructured":"Huang YZ, Kuan CC. Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2022, 26:1770-6. 10.26355\/eurrev_202203_28248","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.24875\/CIRU.21000487","article-title":"Vaccination in the context of the COVID-19 pandemic","volume":"89","author":"D\u00edaz-Badillo \u00c1","year":"2021","unstructured":"D\u00edaz-Badillo \u00c1, Garibay-Nieto GN, Navas-Figueroa AL, Perales-Torres AL, Morales-G\u00f3mez MC, L\u00f3pez-Alvarenga JC. Vaccination in the context of the COVID-19 pandemic. Cir Cir. 2021, 89:836-43. 10.24875\/CIRU.21000487","journal-title":"Cir Cir"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni C","year":"2021","unstructured":"Menni C, Klaser K, May A, et al.. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021, 21:939-49. 10.1016\/S1473-3099(21)00224-3","journal-title":"Lancet Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14125","article-title":"COVID-19 vaccine and hyperosmolar hyperglycemic state","volume":"13","author":"Abu-Rumaileh MA","year":"2021","unstructured":"Abu-Rumaileh MA, Gharaibeh AM, Gharaibeh NE. COVID-19 vaccine and hyperosmolar hyperglycemic state. Cureus. 2021, 13:e14125. 10.7759\/cureus.14125","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.024","article-title":"Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: report of three cases","volume":"15","author":"Mishra A","year":"2021","unstructured":"Mishra A, Ghosh A, Dutta K, Tyagi K, Misra A. Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: report of three cases. Diabetes Metab Syndr. 2021, 15:102151. 10.1016\/j.dsx.2021.05.024","journal-title":"Diabetes Metab Syndr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14631","article-title":"Acute hyperglycaemic crisis after vaccination against COVID-19: a case series","volume":"38","author":"Edwards AE","year":"2021","unstructured":"Edwards AE, Vathenen R, Henson SM, Finer S, Gunganah K. Acute hyperglycaemic crisis after vaccination against COVID-19: a case series. Diabet Med. 2021, 38:e14631. 10.1111\/dme.14631","journal-title":"Diabet Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab141","article-title":"Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion","volume":"5","author":"Lee HJ","year":"2021","unstructured":"Lee HJ, Sajan A, Tomer Y. Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion. J Endocr Soc. 2021, 5:bvab141. 10.1210\/jendso\/bvab141","journal-title":"J Endocr Soc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2021.04.012","article-title":"COVID-19 vaccination in pregnant and lactating diabetic women","volume":"31","author":"Sculli MA","year":"2021","unstructured":"Sculli MA, Formoso G, Sciacca L. COVID-19 vaccination in pregnant and lactating diabetic women. Nutr Metab Cardiovasc Dis. 2021, 31:2151-5. 10.1016\/j.numecd.2021.04.012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2114854","article-title":"Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study","volume":"11","author":"Yan VK","year":"2022","unstructured":"Yan VK, Wan EY, Ye X, et al.. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study. Emerg Microbes Infect. 2022, 11:2304-14. 10.1080\/22221751.2022.2114854","journal-title":"Emerg Microbes Infect"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.840580","article-title":"A case series of ketoacidosis after coronavirus disease 2019 vaccination in patients with type 1 diabetes","volume":"13","author":"Yakou F","year":"2022","unstructured":"Yakou F, Saburi M, Hirose A, et al.. A case series of ketoacidosis after coronavirus disease 2019 vaccination in patients with type 1 diabetes. Front Endocrinol (Lausanne). 2022, 13:840580. 10.3389\/fendo.2022.840580","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102371","article-title":"Diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) temporally related to COVID-19 vaccination","volume":"16","author":"Ganakumar V","year":"2022","unstructured":"Ganakumar V, Jethwani P, Roy A, Shukla R, Mittal M, Garg MK. Diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) temporally related to COVID-19 vaccination. Diabetes Metab Syndr. 2022, 16:102371. 10.1016\/j.dsx.2021.102371","journal-title":"Diabetes Metab Syndr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211043552","article-title":"Severe diabetic ketoacidosis after the second dose of mRNA-1273 COVID-19 vaccine","volume":"16","author":"Zilbermint M","year":"2022","unstructured":"Zilbermint M, Demidowich AP. Severe diabetic ketoacidosis after the second dose of mRNA-1273 COVID-19 vaccine. J Diabetes Sci Technol. 2022, 16:248-9. 10.1177\/19322968211043552","journal-title":"J Diabetes Sci Technol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211026291","article-title":"Analysis of continuous blood glucose data in people with type 1 diabetes (T1DM) after COVID-19 vaccination indicates a possible link between the immune and the metabolic response","volume":"15","author":"Heald AH","year":"2021","unstructured":"Heald AH, Stedman M, Horne L, et al.. Analysis of continuous blood glucose data in people with type 1 diabetes (T1DM) after COVID-19 vaccination indicates a possible link between the immune and the metabolic response. J Diabetes Sci Technol. 2021, 15:1204-5. 10.1177\/19322968211026291","journal-title":"J Diabetes Sci Technol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102738","article-title":"A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination","volume":"125","author":"Patrizio A","year":"2021","unstructured":"Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021, 125:102738. 10.1016\/j.jaut.2021.102738","journal-title":"J Autoimmun"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-021-01837-0","article-title":"Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)","volume":"59","author":"Dicembrini I","year":"2022","unstructured":"Dicembrini I, Vitale V, Cosentino C, et al.. Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS). Acta Diabetol. 2022, 59:435-8. 10.1007\/s00592-021-01837-0","journal-title":"Acta Diabetol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9004-21","article-title":"New-onset type 1 diabetes after COVID-19 mRNA vaccination","volume":"61","author":"Yano M","year":"2022","unstructured":"Yano M, Morioka T, Natsuki Y, et al.. New-onset type 1 diabetes after COVID-19 mRNA vaccination. Intern Med. 2022, 61:1197-200. 10.2169\/internalmedicine.9004-21","journal-title":"Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ph15060677","article-title":"European safety analysis of mRNA and viral vector COVID-19 vaccines on glucose metabolism events","volume":"15","author":"di Mauro G","year":"2022","unstructured":"di Mauro G, Mascolo A, Longo M, et al.. European safety analysis of mRNA and viral vector COVID-19 vaccines on glucose metabolism events. Pharmaceuticals (Basel). 2022, 15:677. 10.3390\/ph15060677","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13771","article-title":"New-onset fulminant type\u20091 diabetes after severe acute respiratory syndrome coronavirus\u20092 vaccination: a case report","volume":"13","author":"Sasaki K","year":"2022","unstructured":"Sasaki K, Morioka T, Okada N, et al.. New-onset fulminant type\u20091 diabetes after severe acute respiratory syndrome coronavirus\u20092 vaccination: a case report. J Diabetes Investig. 2022, 13:1286-9. 10.1111\/jdi.13771","journal-title":"J Diabetes Investig"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101324","article-title":"Fulminant type 1 diabetes after COVID-19 vaccination","volume":"48","author":"Tang X","year":"2022","unstructured":"Tang X, He B, Liu Z, Zhou Z, Li X. Fulminant type 1 diabetes after COVID-19 vaccination. Diabetes Metab. 2022, 48:101324. 10.1016\/j.diabet.2022.101324","journal-title":"Diabetes Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13781","article-title":"Type 1 diabetes mellitus following COVID-19 RNA-based vaccine","volume":"13","author":"Sakurai K","year":"2022","unstructured":"Sakurai K, Narita D, Saito N, et al.. Type 1 diabetes mellitus following COVID-19 RNA-based vaccine. J Diabetes Investig. 2022, 13:1290-2. 10.1111\/jdi.13781","journal-title":"J Diabetes Investig"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6473","article-title":"New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: a case report","volume":"10","author":"Kobayashi T","year":"2022","unstructured":"Kobayashi T, Yakou F, Saburi M, et al.. New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: a case report. Clin Case Rep. 2022, 10:e6473. 10.1002\/ccr3.6473","journal-title":"Clin Case Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111905","article-title":"Fulminant type 1 diabetes mellitus after SARS-CoV-2 vaccination: a case report","volume":"10","author":"Lin R","year":"2022","unstructured":"Lin R, Lin YW, Chen MH. Fulminant type 1 diabetes mellitus after SARS-CoV-2 vaccination: a case report. Vaccines (Basel). 2022, 10:1905. 10.3390\/vaccines10111905","journal-title":"Vaccines (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28830","article-title":"COVID-19 vaccine-induced rapid progression of prediabetes to ketosis-prone diabetes mellitus in an elderly male","volume":"14","author":"Kshetree B","year":"2022","unstructured":"Kshetree B, Lee J, Acharya S. COVID-19 vaccine-induced rapid progression of prediabetes to ketosis-prone diabetes mellitus in an elderly male. Cureus. 2022, 14:e28830. 10.7759\/cureus.28830","journal-title":"Cureus"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13757","article-title":"Newly developed\u2009type 1 diabetes after coronavirus disease 2019 vaccination: a case report","volume":"13","author":"Sasaki H","year":"2022","unstructured":"Sasaki H, Itoh A, Watanabe Y, et al.. Newly developed\u2009type 1 diabetes after coronavirus disease 2019 vaccination: a case report. J Diabetes Investig. 2022, 13:1105-8. 10.1111\/jdi.13757","journal-title":"J Diabetes Investig"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13326","article-title":"COVID-19 vaccination in adolescents and young adults with type 1 diabetes: glycemic control and side effects","volume":"23","author":"Piccini B","year":"2022","unstructured":"Piccini B, Pessina B, Pezzoli F, Casalini E, Toni S. COVID-19 vaccination in adolescents and young adults with type 1 diabetes: glycemic control and side effects. Pediatr Diabetes. 2022, 23:469-72. 10.1111\/pedi.13326","journal-title":"Pediatr Diabetes"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14352","article-title":"Diabetic ketoacidosis shortly after COVID-19 vaccination in a non-small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: a case report","volume":"13","author":"Makiguchi T","year":"2022","unstructured":"Makiguchi T, Fukushima T, Tanaka H, Taima K, Takayasu S, Tasaka S. Diabetic ketoacidosis shortly after COVID-19 vaccination in a non-small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: a case report. Thorac Cancer. 2022, 13:1220-3. 10.1111\/1759-7714.14352","journal-title":"Thorac Cancer"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2337\/db22-0053","article-title":"Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes","volume":"71","author":"D'Addio F","year":"2022","unstructured":"D'Addio F, Sabiu G, Usuelli V, et al.. Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes. Diabetes. 2022, 71:1800-6. 10.2337\/db22-0053","journal-title":"Diabetes"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01796-5","article-title":"COVID-19 vaccine and autoimmune diabetes in adults: report of two cases","volume":"45","author":"Bleve E","year":"2022","unstructured":"Bleve E, Venditti V, Lenzi A, Morano S, Filardi T. COVID-19 vaccine and autoimmune diabetes in adults: report of two cases. J Endocrinol Invest. 2022, 45:1269-70. 10.1007\/s40618-022-01796-5","journal-title":"J Endocrinol Invest"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3201\/eid2807.220127","article-title":"Type 1 diabetes mellitus associated with nivolumab after second SARS-CoV-2 vaccination, Japan","volume":"28","author":"Sato T","year":"2022","unstructured":"Sato T, Kodama S, Kaneko K, Imai J, Katagiri H. Type 1 diabetes mellitus associated with nivolumab after second SARS-CoV-2 vaccination, Japan. Emerg Infect Dis. 2022, 28:1518-20. 10.3201\/eid2807.220127","journal-title":"Emerg Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-022-00614-w","article-title":"Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes","volume":"14","author":"Nishino K","year":"2023","unstructured":"Nishino K, Nakagawa K, Yase E, Terashima M, Murata T. Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes. Diabetol Int. 2023, 14:206-10. 10.1007\/s13340-022-00614-w","journal-title":"Diabetol Int"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e12","article-title":"Adult-onset type 1 diabetes development following COVID-19 mRNA vaccination","volume":"38","author":"Moon H","year":"2023","unstructured":"Moon H, Suh S, Park MK. Adult-onset type 1 diabetes development following COVID-19 mRNA vaccination. J Korean Med Sci. 2023, 38:e12. 10.3346\/jkms.2023.38.e12","journal-title":"J Korean Med Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03130-8","article-title":"Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination","volume":"78","author":"Aydo\u011fan B\u0130","year":"2022","unstructured":"Aydo\u011fan B\u0130, \u00dcnl\u00fct\u00fcrk U, Cesur M. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine. 2022, 78:42-6. 10.1007\/s12020-022-03130-8","journal-title":"Endocrine"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03169-7","article-title":"Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination","volume":"78","author":"Mungmunpuntipantip R","year":"2022","unstructured":"Mungmunpuntipantip R, Wiwanitkit V. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine. 2022, 78:641. 10.1007\/s12020-022-03169-7","journal-title":"Endocrine"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1563","article-title":"Impact of COVID-19 vaccination on glycemia in individuals with type 1 and type 2 diabetes: substudy of the COVAC-DM study","volume":"45","author":"Aberer F","year":"2022","unstructured":"Aberer F, Moser O, Aziz F, et al.. Impact of COVID-19 vaccination on glycemia in individuals with type 1 and type 2 diabetes: substudy of the COVAC-DM study. Diabetes Care. 2022, 45:e24-6. 10.2337\/dc21-1563","journal-title":"Diabetes Care"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2022.100458","article-title":"Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: a prospective study","volume":"35","author":"Carrondo MC","year":"2022","unstructured":"Carrondo MC, Moita JJ. Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: a prospective study. Obes Med. 2022, 35:100458. 10.1016\/j.obmed.2022.100458","journal-title":"Obes Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154936","article-title":"Sodium\/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts","volume":"127","author":"Marfella R","year":"2022","unstructured":"Marfella R, D'Onofrio N, Trotta MC, et al.. Sodium\/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts. Metabolism. 2022, 127:154936. 10.1016\/j.metabol.2021.154936","journal-title":"Metabolism"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/189657-covid-19-vaccination-and-its-relation-to-new-onset-diabetes-a-narrativereview","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:08Z","timestamp":1707509348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/189657-covid-19-vaccination-and-its-relation-to-new-onset-diabetes-a-narrativereview"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.47056","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,15]]}}}